Sign Up to like & get
recommendations!
1
Published in 2022 at "British Journal of Dermatology"
DOI: 10.1111/bjd.21653
Abstract: DEAR EDITOR, a 56-year-old Afro-Caribbean woman was started on atezolizumab and bevacizumab for the treatment of metastatic mesothelioma. She developed a florid blistering eruption affecting the torso and limbs. The bullae formed annular plaques with…
read more here.
Keywords:
iga bullous;
linear iga;
induced linear;
bullous dermatosis ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Dermatologic Therapy"
DOI: 10.1111/dth.12924
Abstract: Immunotherapy has revolutionized cancer therapy in recent years but is associated with unique immunologically mediated adverse effects. Immunotherapy‐induced bullous pemphigoid (BP) is an uncommon but established reaction that portends significant management implications as in most…
read more here.
Keywords:
bullous pemphigoid;
case atezolizumab;
atezolizumab induced;
pemphigoid ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "BMJ Case Reports"
DOI: 10.1136/bcr-2022-250662
Abstract: Atezolizumab is a humanised monoclonal IgG1 antibody that is used in treating many solid malignancies. Endocrinopathies are known but a rare adverse event of these immunotherapeutic drugs. Autoimmune diabetes induced by atezolizumab has been rarely…
read more here.
Keywords:
induced autoimmune;
takotsubo cardiomyopathy;
autoimmune diabetes;
atezolizumab induced ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155220957720
Abstract: Introduction Atezolizumab is currently the only immunotherapy used in conjunction with nab-paclitaxel for locally advanced or triple negative breast cancer. Limited data is available regarding hemolytic anemia as a side effect of atezolizumab. Case report…
read more here.
Keywords:
hemolytic anemia;
atezolizumab induced;
anemia;
case report ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of the Endocrine Society"
DOI: 10.1210/js.2017-00414
Abstract: Cancer immunotherapy has emerged as treatment of multiple advanced cancer types. Immune checkpoint inhibitors, namely anticytotoxic T-lymphocyte antigen-4 (CTLA-4), antiprogrammed cell death-1 (PD-1), and antiprogrammed cell death-1 ligand 1 (PD-L1) antibodies, have been used for…
read more here.
Keywords:
induced hypophysitis;
treatment;
hypophysitis;
atezolizumab induced ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Internal Medicine"
DOI: 10.2169/internalmedicine.8919-21
Abstract: We herein report a case of encephalitis in a 42-year-old woman with hepatocellular carcinoma following atezolizumab plus bevacizumab therapy. After two weeks of treatment, she was admitted for a high fever, impaired consciousness, and convulsive…
read more here.
Keywords:
report;
hepatocellular carcinoma;
case report;
atezolizumab induced ... See more keywords